c-Abl inhibition activates TFEB and promotes cellular clearance in a Niemann-Pick type C (NPC) models, a neurodegenerative disease characterized by cholesterol accumulation in lysosomes [154]. This evidence concerns the gene TFEB and neurodegenerative disease.